Bai, M., Deng, T., Han, R., Zhou, L., & Ba, Y. (2015). Gemcitabine plus S-1 versus cetuximab as a third-line therapy in metastatic colorectal cancer: An observational trial. Int J Clin Exp Med.
Citação norma ChicagoBai, Ming, Ting Deng, Rubing Han, Likun Zhou, e Yi Ba. "Gemcitabine Plus S-1 Versus Cetuximab As a Third-line Therapy in Metastatic Colorectal Cancer: An Observational Trial." Int J Clin Exp Med 2015.
Citação norma MLABai, Ming, et al. "Gemcitabine Plus S-1 Versus Cetuximab As a Third-line Therapy in Metastatic Colorectal Cancer: An Observational Trial." Int J Clin Exp Med 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.